Amyloidosis is a rare condition, in which deposits of extracellular deposition of insoluble fibrillar proteins result in localized or systemic tissue damage. There are several types of inherited or acquired amyloidoses, one of which is caused by a mutation in the transthyretin (TTR) gene. The abnormal TTR protein is produced by the liver, choroid plexus and retinal pigment epithelium (RPE). Pathological investigation showed amyloid deposits on the conjunctiva, cornea, sclera, uveal tract, trabecular meshwork, vitreous body,\[[@ref1][@ref2]\] orbital tissues, and the optic nerve.\[[@ref3]\] Vitreous deposits and secondary glaucoma are the two major ocular complications of TTR-related familial amyloid polyneuropathy.

Case Report {#sec1-1}
===========

A 68-year-old Caucasian woman, with a history of gastritis and light cerebral stroke with leptomeningeal involvement registered by magnetic resonance imaging (MRI), presented with bilateral glass wool-like vitreous opacities and whitish deposits mimicking lens fragments in the right eye. Ultrasonography showed no intraocular masses or retinochoroidal layer thickening. Fluorescein angiography revealed bilateral retinal vascular focal staining without ischemic areas and late hyperfluorescence of the optic disc. Indocyanine green angiography (ICGA) showed late diffuse hyperfluorescent spots overlying retinal vessels \[[Fig. 1a](#F1){ref-type="fig"}\].

![(a) Diffuse intraretinal hyperfluorescent spots overlying retinal vessels (arrows) on indocyanine green angiography; (b) whitish amyloid deposit being removed during pars plana vitrectomy (PPV); (c) amyloid material in the anterior chamber of the right eye; (d) glass wool-like vitreous opacities prior to complete left PPV](IJO-63-72-g001){#F1}

Pathologic examination of amorphous material from a gastric mucosa biopsy and from a 23-gauge nonextensive pars plana vitrectomy (PPV) in the right eye \[[Fig. 1b](#F1){ref-type="fig"}\] showed positive Congo red staining \[[Fig. 2](#F2){ref-type="fig"}\] and confirmed the diagnosis of nonfamilial amyloidosis.\[[@ref4]\] Genetic testing revealed a Tyr114Cys mutation in the TTR gene. Extensive systemic diagnostic work-up ruled out plasma cell disorder and secondary amyloidosis; the patient was on antiplatelet therapy, her blood pressure and erythrocyte sedimentation rate were normal.

![Vitrectomy specimen of the right eye showing Congo red stained amyloid fibrils](IJO-63-72-g002){#F2}

One month after PPV, her right visual acuity had decreased from 20/25 to 20/50, due to recurrent vitreous opacities; her right intraocular pressure (IOP) had peaked at 29 mmHg and subsequently dropped to normal limits with 2% dorzolamide, 0.5% timolol and 0.2% brimonidine eye drops twice daily.

Six months after PPV, thick grayish material consistent with amyloid deposit was found in the right anterior chamber \[[Fig. 1c](#F1){ref-type="fig"}\] and her right visual acuity had deteriorated to counting fingers within 8 weeks, along with moderate vitreous haze. Predominantly glass wool-like vitreous opacities \[[Fig. 1d](#F1){ref-type="fig"}\] required a 23-gauge extensive PPV with IOL implantation in the left eye.

After 1 week, visual acuity in the left eye reached 20/25, IOP was 23 mmHg but dropped to 15 mmHg with the use of a fixed combination of 2% dorzolamide and 0.5% timolol. Spectral domain optical coherence tomography (SD-OCT) evidenced a bilateral epimacular layer of amyloid deposits and numerous reflective spots within the inner retina \[Fig. [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\]; average cup/disk (C/D) ratio was 0.89 and 0.44 in the right and left eye, respectively. Rim area was markedly reduced in the right eye and normal in the left; whereas only the retinal nerve fiber layer (RNFL) thickness in the left eye appeared reduced \[[Fig. 3c](#F3){ref-type="fig"}\]. Both eyes had temporal parapapillary atrophy. Perimetry (Humphrey-Zeiss 750 Field Analyzer) showed severe, mostly nasal, visual field constriction with central defect in the right eye (120 point screening), and mild depression in the left eye (MD - 4.9 dB, 30.2 program). Brain and orbit MRI was unremarkable.

![(a and b) Spectral domain optical coherence tomography shows bilateral epimacular layer of amyloid material and bilateral reflective spots (arrows), mostly located in the inner plexiform layer. (c) Note markedly reduced rim area and markedly increased C/D ratio in the right eye](IJO-63-72-g003){#F3}

One year after PPV in the left eye, severe polyneuropathy, cognitive deterioration, and reversible ischemic neurologic deficit had occurred. Visual acuity was light perception in the right eye and, in 3 months, decreased to 20/400 in the left eye, where mild vitreous opacity, pale cupped (average C/D ratio 0.78) optic disc, inferior altitudinal defect with superonasal extension and central scotoma were found. Bilateral diurnal IOP, checked at bimonthly intervals, never exceeded 16 mmHg with medication.

Discussion {#sec1-2}
==========

Outflow obstruction and raised episcleral pressure are possible mechanisms of secondary glaucoma, that usually develops about 2 years after the onset of pupillary amyloid deposition,\[[@ref5]\] but in the right eye of our patient intraocular hypertension was discovered 6 months prior to amyloid material detection in the anterior chamber. The insidious severe visual acuity and field loss along with well-controlled IOP dictated against secondary glaucoma and was consistent with bilateral optic neuropathy from impaired blood flow in the optic nerve vasculature.

In fact, in most pathologic specimens, amyloid deposits are localized in the vessels of the arterial circle of Zinn-Haller,\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6]\] the optic nerve sheaths and along the choriocapillaris.\[[@ref1]\] The neuroretinal rim loss and optic disc cupping, found in the right eye and afterwards in the left eye of our patient, indicate severe anterior and/or posterior vascular damage to the optic nerve. In our case, the visual loss developed in few weeks, and not over hours or days as typically described in acute anterior or posterior ischemic optic neuropathy.

Beirão *et al*. reported that amyloid deposition (ATTR V30M) recurred only in nonextensive vitrectomized eyes.\[[@ref7]\] However, our patient with late onset nonfamilial amyloidosis and bilateral vitreous deposits recurrence after nonextensive (right eye) and extensive (left eye) PPV had an ATTR Tyr114Cys mutation, in which the prevalence of vitreous opacities (100%) and the recurrence of mild vitreous opacities (20%) after standard PPV is reported much higher than in patients with ATTR V30M mutation (24% and 11%, respectively).\[[@ref8]\]

While late hyperfluorescence of the optic disc and retinal and choroidal vascular focal staining have already been described in ocular amyloidosis,\[[@ref9]\] previously unreported bilateral hyperfluorescent spots found in our patient on ICGA likely correspond to small pinpoint opacities overlying retinal blood vessels, which may be overlooked as vitreous condensations on ophthalmoscopic examination.

In our patient, epimacular amyloid deposits had a rather smooth and not a needle-shape appearance\[[@ref10]\] on SD-OCT examination. She had minimally impaired visual acuity, shortly after complete left vitrectomy. Intraretinal amyloid deposits detection is a previously unreported finding in our patient, and indicates the route of amyloid material from RPE to vitreous chamber. Layered amyloid material caused unreliable measurement of the RNFL thickness in the right eye, where normal RNFL thickness was inconsistent with severe cupping and thinning of the neuroretinal rim.

Conclusion {#sec1-3}
==========

In our patient, both nonextensive and extensive PPV could not prevent the recurrence of bilateral intraocular amyloid deposits. Clinical evidence indicates that amyloidosis can cause bilateral sequential optic atrophy, reasonably due mostly to defective blood supply. SD-OCT can show RPE-derived intraretinal and epiretinal deposits and could provide helpful diagnostic hints in patients with suspicious TTR-related amyloidosis.
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